{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "17",
                "@timestamp": "2023-01-17T07:11:39.000039-05:00",
                "@year": "2023",
                "@month": "01"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2020",
                "@month": "12"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": [
                {"xocs:funding-agency-matched-string": "Ramathibodi Hospital Cancer Center"},
                {
                    "xocs:funding-agency-matched-string": "Mahidol University",
                    "xocs:funding-agency-acronym": "MU",
                    "xocs:funding-agency": "Mahidol University",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100004156",
                    "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"
                }
            ],
            "xocs:funding-addon-generated-timestamp": "2021-06-05T00:04:44.823Z",
            "xocs:funding-text": "The authors thank (a) Suwannee Sirilerttrakul and Somthawin Lukerak for colorectal cancer collections; (b) Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University for the support of facilities; (c) Yupin Wisetpanit for colorectal cancer samples bank; and (d) This study was supported by the grants of the Ramathibodi Hospital Cancer Center, Bangkok, Thailand.",
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60023366",
                            "@country": "tha",
                            "city": "Pathum Thani",
                            "organization": [
                                {"$": "Faculty of Medical Technology"},
                                {"$": "Rangsit University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60023366",
                                "@dptid": "104185763"
                            },
                            "@affiliation-instance-id": "2005815577-d457042a35f377b88ee02b31a5037c35",
                            "ce:source-text": "Faculty of Medical Technology, Rangsit University, Pathum Thani, Thailand",
                            "@dptid": "104185763"
                        },
                        "author": [{
                            "ce:given-name": "Chalirmporn",
                            "preferred-name": {
                                "ce:given-name": "Chalirmporn",
                                "ce:initials": "C.",
                                "ce:surname": "Atasilp",
                                "ce:indexed-name": "Atasilp C."
                            },
                            "@author-instance-id": "2005815577-a4ced25bc8a41efdd77ef6747c9dc986",
                            "@seq": "1",
                            "ce:initials": "C.",
                            "@date-locked": "2021-06-09T06:17:20.000",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Atasilp",
                            "@auid": "56465100500",
                            "ce:indexed-name": "Atasilp C."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60015887",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Division of Medical Oncology"},
                                {"$": "Department of Medicine"},
                                {"$": "Faculty of Medicine Ramathibodi Hospital"},
                                {"$": "Mahidol University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60015887",
                                    "@dptid": "100285976"
                                },
                                {"@afid": "60012718"}
                            ],
                            "@affiliation-instance-id": "2005815577-600fecc2571a810e23d2e0d08478d6d3",
                            "ce:source-text": "Division of Medical Oncology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand",
                            "@dptid": "100285976"
                        },
                        "author": [
                            {
                                "ce:given-name": "Phichai",
                                "preferred-name": {
                                    "ce:given-name": "Phichai",
                                    "ce:initials": "P.",
                                    "ce:surname": "Chansriwong",
                                    "ce:indexed-name": "Chansriwong P."
                                },
                                "@author-instance-id": "2005815577-215ebf50b21b160af51840af04f9f9cd",
                                "@seq": "2",
                                "ce:initials": "P.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Chansriwong",
                                "@auid": "37007308200",
                                "ce:indexed-name": "Chansriwong P."
                            },
                            {
                                "ce:given-name": "Ekaphop",
                                "preferred-name": {
                                    "ce:given-name": "Ekaphop",
                                    "ce:initials": "E.",
                                    "ce:surname": "Sirachainan",
                                    "ce:indexed-name": "Sirachainan E."
                                },
                                "@author-instance-id": "2005815577-9d1cf24e7eb915fd7bdb009cb2cdd427",
                                "@seq": "3",
                                "ce:initials": "E.",
                                "@date-locked": "2023-01-17T07:05:37.814",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Sirachainan",
                                "@auid": "6602792356",
                                "ce:indexed-name": "Sirachainan E."
                            },
                            {
                                "ce:given-name": "Thanyanan",
                                "preferred-name": {
                                    "ce:given-name": "Thanyanan",
                                    "ce:initials": "T.",
                                    "ce:surname": "Reungwetwattana",
                                    "ce:indexed-name": "Reungwetwattana T."
                                },
                                "@author-instance-id": "2005815577-17c006f1d6b343fe97076fe409e5850e",
                                "@seq": "4",
                                "ce:initials": "T.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Reungwetwattana",
                                "@auid": "37120809500",
                                "ce:indexed-name": "Reungwetwattana T."
                            },
                            {
                                "ce:given-name": "Suwannee",
                                "preferred-name": {
                                    "ce:given-name": "Suwannee",
                                    "ce:initials": "S.",
                                    "ce:surname": "Sirilerttrakul",
                                    "ce:indexed-name": "Sirilerttrakul S."
                                },
                                "@author-instance-id": "2005815577-6a4b62297357a147e7f6290213b6fc6a",
                                "@seq": "5",
                                "ce:initials": "S.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Sirilerttrakul",
                                "@auid": "7801642293",
                                "ce:indexed-name": "Sirilerttrakul S."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Clinical Pharmacokinetics and Pharmacogenomics Research Unit"},
                                {"$": "Department of Pharmacology"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60028190",
                                "@dptid": "104425668"
                            },
                            "@affiliation-instance-id": "2005815577-d7d6cad757997f74621f88b5a60c6dff",
                            "ce:source-text": "Clinical Pharmacokinetics and Pharmacogenomics Research Unit, Department of Pharmacology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand",
                            "@dptid": "104425668"
                        },
                        "author": [{
                            "ce:given-name": "Monpat",
                            "preferred-name": {
                                "ce:given-name": "Monpat",
                                "ce:initials": "M.",
                                "ce:surname": "Chamnanphon",
                                "ce:indexed-name": "Chamnanphon M."
                            },
                            "@author-instance-id": "2005815577-e0a169e6e51bbba35cccc056f8bd400f",
                            "@seq": "6",
                            "ce:initials": "M.",
                            "@date-locked": "2022-01-09T22:44:41.212",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Chamnanphon",
                            "@auid": "55441642400",
                            "ce:indexed-name": "Chamnanphon M."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "postal-code": "10400",
                            "@afid": "60015887",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Division of Pharmacogenomics and Personalized Medicine"},
                                {"$": "Department of Pathology"},
                                {"$": "Faculty of Medicine Ramathibodi Hospital"},
                                {"$": "Mahidol University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60015887",
                                    "@dptid": "113257643"
                                },
                                {"@afid": "60012718"}
                            ],
                            "@affiliation-instance-id": "2005815577-e481b6c7617330a7d4be11c748ec247e",
                            "ce:source-text": "Division of Pharmacogenomics and Personalized Medicine, Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, 10400, Thailand",
                            "@dptid": "113257643"
                        },
                        "author": [
                            {
                                "ce:given-name": "Chalirmporn",
                                "preferred-name": {
                                    "ce:given-name": "Chalirmporn",
                                    "ce:initials": "C.",
                                    "ce:surname": "Atasilp",
                                    "ce:indexed-name": "Atasilp C."
                                },
                                "@author-instance-id": "2005815577-a4ced25bc8a41efdd77ef6747c9dc986",
                                "@seq": "1",
                                "ce:initials": "C.",
                                "@date-locked": "2021-06-09T06:17:20.000",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Atasilp",
                                "@auid": "56465100500",
                                "ce:indexed-name": "Atasilp C."
                            },
                            {
                                "ce:given-name": "Apichaya",
                                "preferred-name": {
                                    "ce:given-name": "Apichaya",
                                    "ce:initials": "A.",
                                    "ce:surname": "Puangpetch",
                                    "ce:indexed-name": "Puangpetch A."
                                },
                                "@author-instance-id": "2005815577-f80268b34b5f9a6f15b97565abbb8f10",
                                "@seq": "7",
                                "ce:initials": "A.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Puangpetch",
                                "@auid": "55200307900",
                                "ce:indexed-name": "Puangpetch A."
                            },
                            {
                                "ce:given-name": "Chonlaphat",
                                "preferred-name": {
                                    "ce:given-name": "Chonlaphat",
                                    "ce:initials": "C.",
                                    "ce:surname": "Sukasem",
                                    "ce:indexed-name": "Sukasem C."
                                },
                                "@author-instance-id": "2005815577-d4a78dff16c53af24c85698b9390ded7",
                                "@seq": "8",
                                "ce:initials": "C.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Sukasem",
                                "@auid": "57209265337",
                                "@orcid": "0000-0003-0033-5321",
                                "ce:indexed-name": "Sukasem C."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60199578",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Laboratory for Pharmacogenomics"},
                                {"$": "Clinical Pathology"},
                                {"$": "Somdetch Phra Debharatana Medical Centre"},
                                {"$": "Ramathibodi Hospital"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60199578",
                                    "@dptid": "125771267"
                                },
                                {"@afid": "60015887"}
                            ],
                            "@affiliation-instance-id": "2005815577-cb63001f7521f502f7c482bff4d6567a",
                            "ce:source-text": "Laboratory for Pharmacogenomics, Clinical Pathology, Somdetch Phra Debharatana Medical Centre, Ramathibodi Hospital, Bangkok, Thailand",
                            "@dptid": "125771267"
                        },
                        "author": [
                            {
                                "ce:given-name": "Chalirmporn",
                                "preferred-name": {
                                    "ce:given-name": "Chalirmporn",
                                    "ce:initials": "C.",
                                    "ce:surname": "Atasilp",
                                    "ce:indexed-name": "Atasilp C."
                                },
                                "@author-instance-id": "2005815577-a4ced25bc8a41efdd77ef6747c9dc986",
                                "@seq": "1",
                                "ce:initials": "C.",
                                "@date-locked": "2021-06-09T06:17:20.000",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Atasilp",
                                "@auid": "56465100500",
                                "ce:indexed-name": "Atasilp C."
                            },
                            {
                                "ce:given-name": "Apichaya",
                                "preferred-name": {
                                    "ce:given-name": "Apichaya",
                                    "ce:initials": "A.",
                                    "ce:surname": "Puangpetch",
                                    "ce:indexed-name": "Puangpetch A."
                                },
                                "@author-instance-id": "2005815577-f80268b34b5f9a6f15b97565abbb8f10",
                                "@seq": "7",
                                "ce:initials": "A.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Puangpetch",
                                "@auid": "55200307900",
                                "ce:indexed-name": "Puangpetch A."
                            },
                            {
                                "ce:given-name": "Chonlaphat",
                                "preferred-name": {
                                    "ce:given-name": "Chonlaphat",
                                    "ce:initials": "C.",
                                    "ce:surname": "Sukasem",
                                    "ce:indexed-name": "Sukasem C."
                                },
                                "@author-instance-id": "2005815577-d4a78dff16c53af24c85698b9390ded7",
                                "@seq": "8",
                                "ce:initials": "C.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Sukasem",
                                "@auid": "57209265337",
                                "ce:indexed-name": "Sukasem C."
                            }
                        ]
                    }
                ],
                "citation-title": "Effect of drug metabolizing enzymes and transporters in Thai colorectal cancer patients treated with irinotecan-based chemotherapy",
                "abstracts": "© 2020, The Author(s).Genetic polymorphisms in drug metabolizing enzymes and drug transporters may affect irinotecan toxicity. Although genetic polymorphisms have been shown to influence the irinotecan toxicity, data are limited in Thai population. Thus, the aim of this study was to assess the allele and genotype frequencies and the relationship between CYP3A4/5, DPYD, UGT1A1, ABCB1, and ABCC2 genetic variations and irinotecan-induced toxicity in Thai colorectal cancer patients. One hundred and thirty-two patients were genotyped, and the effect of genetic variations on irinotecan-induced toxicity was assessed in 66 patients who received irinotecan-based chemotherapy. Allele frequencies of ABCB1 c.1236C > T, ABCB1 c.3435C > T, ABCC2 c.3972C > T, ABCG2 c.421C > A, CYP3A4*1B, CYP3A4*18, CYP3A5*3, DPYD*5, UGT1A1*28, and UGT1A1*6 were 0.67, 0.43, 0.23, 0.27, 0.01, 0.02, 0.64, 0.19, 0.16, and 0.09, respectively. DPYD*2A and DPYD c.1774C > T variants were not detected in our study population. The ABCC2 c.3972C > T was significantly associated with grade 1\u20134 neutropenia (P < 0.012) at the first cycle. Patients carrying both UGT1A1*28 and *6 were significantly associated with severe neutropenia at the first (P < 0.001) and second (P = 0.017) cycles. In addition, patients carrying UG1A1*28 and *6 had significantly lower absolute neutrophil count (ANC) nadir at first (P < 0.001) and second (P = 0.001) cycles. This finding suggests that UGT1A1*28, *6, and ABCC2 c.3972C > T might be an important predictor for irinotecan-induced severe neutropenia.",
                "correspondence": {
                    "affiliation": {
                        "country": "Thailand",
                        "postal-code": "10400",
                        "@country": "tha",
                        "city": "Bangkok",
                        "organization": [
                            {"$": "Division of Pharmacogenomics and Personalized Medicine"},
                            {"$": "Department of Pathology"},
                            {"$": "Faculty of Medicine Ramathibodi Hospital"},
                            {"$": "Mahidol University"}
                        ],
                        "ce:source-text": "Division of Pharmacogenomics and Personalized Medicine, Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, 10400, Thailand"
                    },
                    "person": {
                        "ce:given-name": "Chonlaphat",
                        "ce:initials": "C.",
                        "ce:surname": "Sukasem",
                        "ce:indexed-name": "Sukasem C."
                    }
                },
                "citation-info": {
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "website": {"ce:e-address": {
                        "$": "www.nature.com/srep/index.html",
                        "@type": "email"
                    }},
                    "translated-sourcetitle": {
                        "$": "Scientific Reports",
                        "@xml:lang": "eng"
                    },
                    "volisspag": {"voliss": {
                        "@volume": "10",
                        "@issue": "1"
                    }},
                    "@type": "j",
                    "sourcetitle": "Scientific Reports",
                    "publicationdate": {
                        "month": "12",
                        "year": "2020",
                        "date-text": {
                            "@xfab-added": "true",
                            "$": "1 December 2020"
                        },
                        "day": "01"
                    },
                    "sourcetitle-abbrev": "Sci. Rep.",
                    "@country": "gbr",
                    "issn": {
                        "$": "20452322",
                        "@type": "electronic"
                    },
                    "publicationyear": {"@first": "2020"},
                    "publisher": {"publishername": "Nature Research"},
                    "article-number": "13486",
                    "@srcid": "21100200805"
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "ASJC",
                            "classification": "1000"
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": "MULT"
                        }
                    ]},
                    "chemicalgroup": {"chemicals": [
                        {
                            "@source": "esbd",
                            "chemical": [
                                {
                                    "cas-registry-number": "80700-39-6",
                                    "chemical-name": "carrier protein"
                                },
                                {
                                    "cas-registry-number": "329322-82-9",
                                    "chemical-name": "cytochrome P450 3A"
                                },
                                {
                                    "cas-registry-number": [
                                        {"$": "37329-64-9"},
                                        {"$": "9030-08-4"}
                                    ],
                                    "enzyme-commission-number": "EC 2.4.1.17",
                                    "chemical-name": "glucuronosyltransferase"
                                },
                                {
                                    "cas-registry-number": [
                                        {"$": "100286-90-6"},
                                        {"$": "97682-44-5"}
                                    ],
                                    "chemical-name": "irinotecan"
                                }
                            ]
                        },
                        {
                            "@source": "nlm",
                            "chemical": [
                                {"chemical-name": "ATP Binding Cassette Transporter, Subfamily B, Member 1"},
                                {"chemical-name": "ATP-Binding Cassette Transporters"},
                                {"chemical-name": "Cytochrome P-450 CYP3A"},
                                {"chemical-name": "Glucuronosyltransferase"},
                                {"chemical-name": "Irinotecan"},
                                {"chemical-name": "Membrane Transport Proteins"},
                                {"chemical-name": "multidrug resistance-associated protein 2"},
                                {"chemical-name": "Multidrug Resistance-Associated Proteins"},
                                {"chemical-name": "UGT1A1 enzyme"}
                            ]
                        }
                    ]}
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2020 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "dbcollection": [
                    {"$": "NURSNG"},
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "SNSOC"},
                    {"$": "Scopusbase"},
                    {"$": "MEDL"}
                ],
                "history": {"date-created": {
                    "@day": "13",
                    "@timestamp": "BST 04:43:39",
                    "@year": "2020",
                    "@month": "08"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2005815577",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "927623979",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "2020307021",
                            "@idtype": "NURSNG"
                        },
                        {
                            "$": "20201711322",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20202895264",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "2020089305",
                            "@idtype": "SNSOC"
                        },
                        {
                            "$": "20200012736556",
                            "@idtype": "TPA-ID"
                        },
                        {
                            "$": "85089227432",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85089227432",
                            "@idtype": "SGR"
                        },
                        {
                            "$": "632585128",
                            "@idtype": "PUIsecondary"
                        },
                        {
                            "$": "32778670",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "298817299",
                            "@idtype": "OSIN"
                        }
                    ],
                    "ce:doi": "10.1038/s41598-020-70351-0"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "41",
                "reference": [
                    {
                        "ref-fulltext": "Innocenti, F. et al. Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan. J. Clin. Oncol. 22, 1382\u20131388. 10.1200/jco.2004.07.173 (2004). DOI: 10.1200/jco.2004.07.173",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2004"},
                            "ref-title": {"ref-titletext": "Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1200/jco.2004.07.173",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR1",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "2342459714",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "22"},
                                "pagerange": {
                                    "@first": "1382",
                                    "@last": "1388"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "F.",
                                    "@_fa": "true",
                                    "ce:surname": "Innocenti",
                                    "ce:indexed-name": "Innocenti F."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Clin. Oncol."
                        },
                        "ce:source-text": "Innocenti, F. et al. Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan. J. Clin. Oncol. 22, 1382\u20131388. 10.1200/jco.2004.07.173 (2004). DOI: 10.1200/jco.2004.07.173"
                    },
                    {
                        "ref-fulltext": "Ishida, H. et al. Regimen selection for first-line FOLFIRI and FOLFOX based on UGT1A1 genotype and physical background is feasible in Japanese patients with advanced colorectal cancer. Jpn. J. Clin. Oncol. 41, 617\u2013623. 10.1093/jjco/hyr010 (2011). DOI: 10.1093/jjco/hyr010",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Regimen selection for first-line FOLFIRI and FOLFOX based on UGT1A1 genotype and physical background is feasible in Japanese patients with advanced colorectal cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1093/jjco/hyr010",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR2",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "79955893939",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "41"},
                                "pagerange": {
                                    "@first": "617",
                                    "@last": "623"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Ishida",
                                    "ce:indexed-name": "Ishida H."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Jpn. J. Clin. Oncol."
                        },
                        "ce:source-text": "Ishida, H. et al. Regimen selection for first-line FOLFIRI and FOLFOX based on UGT1A1 genotype and physical background is feasible in Japanese patients with advanced colorectal cancer. Jpn. J. Clin. Oncol. 41, 617\u2013623. 10.1093/jjco/hyr010 (2011). DOI: 10.1093/jjco/hyr010"
                    },
                    {
                        "ref-fulltext": "Fuchs, C. S. et al. Phase III comparison of two irinotecan dosing regimens in second-line therapy of metastatic colorectal cancer. J. Clin. Oncol. 21, 807\u2013814 (2003). DOI: 10.1200/JCO.2003.08.058",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2003"},
                            "ref-title": {"ref-titletext": "Phase III comparison of two irinotecan dosing regimens in second-line therapy of metastatic colorectal cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1200/JCO.2003.08.058",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR3",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0037364658",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "21"},
                                "pagerange": {
                                    "@first": "807",
                                    "@last": "814"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DC%2BD2cXpsVGru7k%3D",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "C.S.",
                                    "@_fa": "true",
                                    "ce:surname": "Fuchs",
                                    "ce:indexed-name": "Fuchs C.S."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Clin. Oncol."
                        },
                        "ce:source-text": "Fuchs, C. S. et al. Phase III comparison of two irinotecan dosing regimens in second-line therapy of metastatic colorectal cancer. J. Clin. Oncol. 21, 807\u2013814 (2003). DOI: 10.1200/JCO.2003.08.058"
                    },
                    {
                        "ref-fulltext": "Bencharit, S. et al. Structural insights into CPT-11 activation by mammalian carboxylesterases. Nat. Struct. Biol. 9, 337\u2013342. 10.1038/nsb790 (2002). DOI: 10.1038/nsb790",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2002"},
                            "ref-title": {"ref-titletext": "Structural insights into CPT-11 activation by mammalian carboxylesterases"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1038/nsb790",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR4",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0036234884",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "9"},
                                "pagerange": {
                                    "@first": "337",
                                    "@last": "342"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Bencharit",
                                    "ce:indexed-name": "Bencharit S."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nat. Struct. Biol."
                        },
                        "ce:source-text": "Bencharit, S. et al. Structural insights into CPT-11 activation by mammalian carboxylesterases. Nat. Struct. Biol. 9, 337\u2013342. 10.1038/nsb790 (2002). DOI: 10.1038/nsb790"
                    },
                    {
                        "ref-fulltext": "Cresteil, T. et al. Regioselective metabolism of taxoids by human CYP3A4 and 2C8: Structure\u2013activity relationship. Drug Metab. Dispos. 30, 438\u2013445 (2002). DOI: 10.1124/dmd.30.4.438",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2002"},
                            "ref-title": {"ref-titletext": "Regioselective metabolism of taxoids by human CYP3A4 and 2C8: Structure\u2013activity relationship"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1124/dmd.30.4.438",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR5",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0036201599",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "30"},
                                "pagerange": {
                                    "@first": "438",
                                    "@last": "445"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DC%2BD38Xis1OlsLk%3D",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "Cresteil",
                                    "ce:indexed-name": "Cresteil T."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Drug Metab. Dispos."
                        },
                        "ce:source-text": "Cresteil, T. et al. Regioselective metabolism of taxoids by human CYP3A4 and 2C8: Structure\u2013activity relationship. Drug Metab. Dispos. 30, 438\u2013445 (2002). DOI: 10.1124/dmd.30.4.438"
                    },
                    {
                        "ref-fulltext": "Allen, J. D., Brinkhuis, R. F., van Deemter, L., Wijnholds, J. & Schinkel, A. H. Extensive contribution of the multidrug transporters P-glycoprotein and Mrp1 to basal drug resistance. Cancer Res. 60, 5761\u20135766 (2000).",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2000"},
                            "ref-title": {"ref-titletext": "Extensive contribution of the multidrug transporters P-glycoprotein and Mrp1 to basal drug resistance"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CR6",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0034667390",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "60"},
                                "pagerange": {
                                    "@first": "5761",
                                    "@last": "5766"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DC%2BD3cXnvVSntrg%3D, PID: 11059771",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J.D.",
                                    "@_fa": "true",
                                    "ce:surname": "Allen",
                                    "ce:indexed-name": "Allen J.D."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "R.F.",
                                    "@_fa": "true",
                                    "ce:surname": "Brinkhuis",
                                    "ce:indexed-name": "Brinkhuis R.F."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "van Deemter",
                                    "ce:indexed-name": "van Deemter L."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Wijnholds",
                                    "ce:indexed-name": "Wijnholds J."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "A.H.",
                                    "@_fa": "true",
                                    "ce:surname": "Schinkel",
                                    "ce:indexed-name": "Schinkel A.H."
                                }
                            ]},
                            "ref-sourcetitle": "Cancer Res."
                        },
                        "ce:source-text": "Allen, J. D., Brinkhuis, R. F., van Deemter, L., Wijnholds, J. & Schinkel, A. H. Extensive contribution of the multidrug transporters P-glycoprotein and Mrp1 to basal drug resistance. Cancer Res. 60, 5761\u20135766 (2000)."
                    },
                    {
                        "ref-fulltext": "Nagar, S. & Blanchard, R. L. Pharmacogenetics of uridine diphosphoglucuronosyltransferase (UGT) 1A family members and its role in patient response to irinotecan. Drug Metab. Rev. 38, 393\u2013409. 10.1080/03602530600739835 (2006). DOI: 10.1080/03602530600739835",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Pharmacogenetics of uridine diphosphoglucuronosyltransferase (UGT) 1A family members and its role in patient response to irinotecan"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1080/03602530600739835",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR7",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "33746780621",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "38"},
                                "pagerange": {
                                    "@first": "393",
                                    "@last": "409"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Nagar",
                                    "ce:indexed-name": "Nagar S."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "R.L.",
                                    "@_fa": "true",
                                    "ce:surname": "Blanchard",
                                    "ce:indexed-name": "Blanchard R.L."
                                }
                            ]},
                            "ref-sourcetitle": "Drug Metab. Rev."
                        },
                        "ce:source-text": "Nagar, S. & Blanchard, R. L. Pharmacogenetics of uridine diphosphoglucuronosyltransferase (UGT) 1A family members and its role in patient response to irinotecan. Drug Metab. Rev. 38, 393\u2013409. 10.1080/03602530600739835 (2006). DOI: 10.1080/03602530600739835"
                    },
                    {
                        "ref-fulltext": "Smith, N. F., Figg, W. D. & Sparreboom, A. Pharmacogenetics of irinotecan metabolism and transport: An update. Toxicol. In Vitro 20, 163\u2013175. 10.1016/j.tiv.2005.06.045 (2006). DOI: 10.1016/j.tiv.2005.06.045",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Pharmacogenetics of irinotecan metabolism and transport: An update"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.tiv.2005.06.045",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR8",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "30644464675",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "20"},
                                "pagerange": {
                                    "@first": "163",
                                    "@last": "175"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "N.F.",
                                    "@_fa": "true",
                                    "ce:surname": "Smith",
                                    "ce:indexed-name": "Smith N.F."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "W.D.",
                                    "@_fa": "true",
                                    "ce:surname": "Figg",
                                    "ce:indexed-name": "Figg W.D."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Sparreboom",
                                    "ce:indexed-name": "Sparreboom A."
                                }
                            ]},
                            "ref-sourcetitle": "Toxicol. In Vitro"
                        },
                        "ce:source-text": "Smith, N. F., Figg, W. D. & Sparreboom, A. Pharmacogenetics of irinotecan metabolism and transport: An update. Toxicol. In Vitro 20, 163\u2013175. 10.1016/j.tiv.2005.06.045 (2006). DOI: 10.1016/j.tiv.2005.06.045"
                    },
                    {
                        "ref-fulltext": "Ando, Y. & Hasegawa, Y. Clinical pharmacogenetics of irinotecan (CPT-11). Drug Metab. Rev. 37, 565\u2013574. 10.1080/03602530500316254 (2005). DOI: 10.1080/03602530500316254",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2005"},
                            "ref-title": {"ref-titletext": "Clinical pharmacogenetics of irinotecan (CPT-11)"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1080/03602530500316254",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR9",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "26444594410",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "37"},
                                "pagerange": {
                                    "@first": "565",
                                    "@last": "574"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Ando",
                                    "ce:indexed-name": "Ando Y."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Hasegawa",
                                    "ce:indexed-name": "Hasegawa Y."
                                }
                            ]},
                            "ref-sourcetitle": "Drug Metab. Rev."
                        },
                        "ce:source-text": "Ando, Y. & Hasegawa, Y. Clinical pharmacogenetics of irinotecan (CPT-11). Drug Metab. Rev. 37, 565\u2013574. 10.1080/03602530500316254 (2005). DOI: 10.1080/03602530500316254"
                    },
                    {
                        "ref-fulltext": "Huang, S. H. et al. Concurrence of UGT1A polymorphism and end-stage renal disease leads to severe toxicities of irinotecan in a patient with metastatic colon cancer. Tumori 97, 243\u2013247. 10.1700/667.7793 (2011). DOI: 10.1700/667.7793",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Concurrence of UGT1A polymorphism and end-stage renal disease leads to severe toxicities of irinotecan in a patient with metastatic colon cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1700/667.7793",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR10",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "79957648257",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "97"},
                                "pagerange": {
                                    "@first": "243",
                                    "@last": "247"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "S.H.",
                                    "@_fa": "true",
                                    "ce:surname": "Huang",
                                    "ce:indexed-name": "Huang S.H."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Tumori"
                        },
                        "ce:source-text": "Huang, S. H. et al. Concurrence of UGT1A polymorphism and end-stage renal disease leads to severe toxicities of irinotecan in a patient with metastatic colon cancer. Tumori 97, 243\u2013247. 10.1700/667.7793 (2011). DOI: 10.1700/667.7793"
                    },
                    {
                        "ref-fulltext": "Takano, M. et al. Clinical significance of UDP-glucuronosyltransferase 1A1*6 for toxicities of combination chemotherapy with irinotecan and cisplatin in gynecologic cancers: A prospective multi-institutional study. Oncology 76, 315\u2013321. 10.1159/000209335 (2009). DOI: 10.1159/000209335",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Clinical significance of UDP-glucuronosyltransferase 1A1*6 for toxicities of combination chemotherapy with irinotecan and cisplatin in gynecologic cancers: A prospective multi-institutional study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1159/000209335",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR11",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "62449216350",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "76"},
                                "pagerange": {
                                    "@first": "315",
                                    "@last": "321"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Takano",
                                    "ce:indexed-name": "Takano M."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Oncology"
                        },
                        "ce:source-text": "Takano, M. et al. Clinical significance of UDP-glucuronosyltransferase 1A1*6 for toxicities of combination chemotherapy with irinotecan and cisplatin in gynecologic cancers: A prospective multi-institutional study. Oncology 76, 315\u2013321. 10.1159/000209335 (2009). DOI: 10.1159/000209335"
                    },
                    {
                        "ref-fulltext": "Miura, M. et al. Influence of drug transporters and UGT polymorphisms on pharmacokinetics of phenolic glucuronide metabolite of mycophenolic acid in Japanese renal transplant recipients. Ther. Drug Monit. 30, 559\u2013564. 10.1097/FTD.0b013e3181838063 (2008). DOI: 10.1097/FTD.0b013e3181838063",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Influence of drug transporters and UGT polymorphisms on pharmacokinetics of phenolic glucuronide metabolite of mycophenolic acid in Japanese renal transplant recipients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1097/FTD.0b013e3181838063",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR12",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "55349106941",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "30"},
                                "pagerange": {
                                    "@first": "559",
                                    "@last": "564"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Miura",
                                    "ce:indexed-name": "Miura M."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ther. Drug Monit."
                        },
                        "ce:source-text": "Miura, M. et al. Influence of drug transporters and UGT polymorphisms on pharmacokinetics of phenolic glucuronide metabolite of mycophenolic acid in Japanese renal transplant recipients. Ther. Drug Monit. 30, 559\u2013564. 10.1097/FTD.0b013e3181838063 (2008). DOI: 10.1097/FTD.0b013e3181838063"
                    },
                    {
                        "ref-fulltext": "Mathijssen, R. H. et al. Irinotecan pathway genotype analysis to predict pharmacokinetics. Clin. Cancer Res. 9, 3246\u20133253 (2003).",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2003"},
                            "ref-title": {"ref-titletext": "Irinotecan pathway genotype analysis to predict pharmacokinetics"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CR13",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0042196122",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "9"},
                                "pagerange": {
                                    "@first": "3246",
                                    "@last": "3253"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DC%2BD3sXotFCksL8%3D, PID: 12960109",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "R.H.",
                                    "@_fa": "true",
                                    "ce:surname": "Mathijssen",
                                    "ce:indexed-name": "Mathijssen R.H."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin. Cancer Res."
                        },
                        "ce:source-text": "Mathijssen, R. H. et al. Irinotecan pathway genotype analysis to predict pharmacokinetics. Clin. Cancer Res. 9, 3246\u20133253 (2003)."
                    },
                    {
                        "ref-fulltext": "Siegsmund, M. et al. Association of the P-glycoprotein transporter MDR1(C3435T) polymorphism with the susceptibility to renal epithelial tumors. J. Am. Soc. Nephrol. 13, 1847\u20131854 (2002). DOI: 10.1097/01.ASN.0000019412.87412.BC",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2002"},
                            "ref-title": {"ref-titletext": "Association of the P-glycoprotein transporter MDR1(C3435T) polymorphism with the susceptibility to renal epithelial tumors"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CR14",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "10.1097/01.ASN.0000019412.87412.BC",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "18444404305",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "13"},
                                "pagerange": {
                                    "@first": "1847",
                                    "@last": "1854"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DC%2BD38XlvVSqt7w%3D",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Siegsmund",
                                    "ce:indexed-name": "Siegsmund M."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Am. Soc. Nephrol."
                        },
                        "ce:source-text": "Siegsmund, M. et al. Association of the P-glycoprotein transporter MDR1(C3435T) polymorphism with the susceptibility to renal epithelial tumors. J. Am. Soc. Nephrol. 13, 1847\u20131854 (2002). DOI: 10.1097/01.ASN.0000019412.87412.BC"
                    },
                    {
                        "ref-fulltext": "Drescher, S. et al. MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadine. Br. J. Clin. Pharmacol. 53, 526\u2013534 (2002). DOI: 10.1046/j.1365-2125.2002.01591.x",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2002"},
                            "ref-title": {"ref-titletext": "MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadine"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1046/j.1365-2125.2002.01591.x",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR15",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0035999902",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "53"},
                                "pagerange": {
                                    "@first": "526",
                                    "@last": "534"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DC%2BD38Xks1Omsr0%3D",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Drescher",
                                    "ce:indexed-name": "Drescher S."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Br. J. Clin. Pharmacol."
                        },
                        "ce:source-text": "Drescher, S. et al. MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadine. Br. J. Clin. Pharmacol. 53, 526\u2013534 (2002). DOI: 10.1046/j.1365-2125.2002.01591.x"
                    },
                    {
                        "ref-fulltext": "Innocenti, F. et al. Pharmacogenetic analysis of interindividual irinotecan (CPT-11) pharmacokinetic (PK) variability: Evidence for a functional variant of ABCC2. J. Clin. Oncol. 22, 2010. 10.1200/jco.2004.22.90140.2010 (2004). DOI: 10.1200/jco.2004.22.90140.2010",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2004"},
                            "ref-title": {"ref-titletext": "Pharmacogenetic analysis of interindividual irinotecan pharmacokinetic variability: Evidence for functional variant of ABCC2"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1200/jco.2004.22.90140.2010",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR16",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "6344282495",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "22"},
                                "pagerange": {"@first": "2010"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "F.",
                                    "@_fa": "true",
                                    "ce:surname": "Innocenti",
                                    "ce:indexed-name": "Innocenti F."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.D.",
                                    "@_fa": "true",
                                    "ce:surname": "Undevia",
                                    "ce:indexed-name": "Undevia S.D."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "P.X.",
                                    "@_fa": "true",
                                    "ce:surname": "Chen",
                                    "ce:indexed-name": "Chen P.X."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Das",
                                    "ce:indexed-name": "Das S."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Ramirez",
                                    "ce:indexed-name": "Ramirez J."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "M.E.",
                                    "@_fa": "true",
                                    "ce:surname": "Dolan",
                                    "ce:indexed-name": "Dolan M.E."
                                },
                                {
                                    "@seq": "7",
                                    "ce:initials": "M.V.",
                                    "@_fa": "true",
                                    "ce:surname": "Relling",
                                    "ce:indexed-name": "Relling M.V."
                                },
                                {
                                    "@seq": "8",
                                    "ce:initials": "D.L.",
                                    "@_fa": "true",
                                    "ce:surname": "Kroetz",
                                    "ce:indexed-name": "Kroetz D.L."
                                },
                                {
                                    "@seq": "9",
                                    "ce:initials": "M.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Ratain",
                                    "ce:indexed-name": "Ratain M.J."
                                }
                            ]},
                            "ref-sourcetitle": "J. Clin. Oncol."
                        },
                        "ce:source-text": "Innocenti, F. et al. Pharmacogenetic analysis of interindividual irinotecan (CPT-11) pharmacokinetic (PK) variability: Evidence for a functional variant of ABCC2. J. Clin. Oncol. 22, 2010. 10.1200/jco.2004.22.90140.2010 (2004). DOI: 10.1200/jco.2004.22.90140.2010"
                    },
                    {
                        "ref-fulltext": "Sparreboom, A. et al. Diflomotecan pharmacokinetics in relation to ABCG2 421C>A genotype. Clin. Pharmacol. Ther. 76, 38\u201344. 10.1016/j.clpt.2004.03.003 (2004). DOI: 10.1016/j.clpt.2004.03.003",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2004"},
                            "ref-title": {"ref-titletext": "Diflomotecan pharmacokinetics in relation to ABCG2 421C>A genotype"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.clpt.2004.03.003",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR17",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "3042651340",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "76"},
                                "pagerange": {
                                    "@first": "38",
                                    "@last": "44"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Sparreboom",
                                    "ce:indexed-name": "Sparreboom A."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin. Pharmacol. Ther."
                        },
                        "ce:source-text": "Sparreboom, A. et al. Diflomotecan pharmacokinetics in relation to ABCG2 421C>A genotype. Clin. Pharmacol. Ther. 76, 38\u201344. 10.1016/j.clpt.2004.03.003 (2004). DOI: 10.1016/j.clpt.2004.03.003"
                    },
                    {
                        "ref-fulltext": "Gentile, G. et al. Genotype\u2013phenotype correlations in 5-fluorouracil metabolism: A candidate DPYD haplotype to improve toxicity prediction. Pharmacogenom. J. 16, 320\u2013325. 10.1038/tpj.2015.56 (2016). DOI: 10.1038/tpj.2015.56",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Genotype\u2013phenotype correlations in 5-fluorouracil metabolism: A candidate DPYD haplotype to improve toxicity prediction"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1038/tpj.2015.56",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR18",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84938387725",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "16"},
                                "pagerange": {
                                    "@first": "320",
                                    "@last": "325"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "G.",
                                    "@_fa": "true",
                                    "ce:surname": "Gentile",
                                    "ce:indexed-name": "Gentile G."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Pharmacogenom. J."
                        },
                        "ce:source-text": "Gentile, G. et al. Genotype\u2013phenotype correlations in 5-fluorouracil metabolism: A candidate DPYD haplotype to improve toxicity prediction. Pharmacogenom. J. 16, 320\u2013325. 10.1038/tpj.2015.56 (2016). DOI: 10.1038/tpj.2015.56"
                    },
                    {
                        "ref-fulltext": "Sukasem, C. et al. Development of pyrosequencing method for detection of UGT1A1 polymorphisms in thai colorectal cancers. J. Clin. Lab. Anal. 30, 84\u201389. 10.1002/jcla.21820 (2016). DOI: 10.1002/jcla.21820",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Development of pyrosequencing method for detection of UGT1A1 polymorphisms in thai colorectal cancers"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1002/jcla.21820",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR19",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84954076213",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "30"},
                                "pagerange": {
                                    "@first": "84",
                                    "@last": "89"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Sukasem",
                                    "ce:indexed-name": "Sukasem C."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Clin. Lab. Anal."
                        },
                        "ce:source-text": "Sukasem, C. et al. Development of pyrosequencing method for detection of UGT1A1 polymorphisms in thai colorectal cancers. J. Clin. Lab. Anal. 30, 84\u201389. 10.1002/jcla.21820 (2016). DOI: 10.1002/jcla.21820"
                    },
                    {
                        "ref-fulltext": "Hoskins, J. M., Goldberg, R. M., Qu, P., Ibrahim, J. G. & McLeod, H. L. UGT1A1*28 genotype and irinotecan-induced neutropenia: Dose matters. J. Natl. Cancer Inst. 99, 1290\u20131295. 10.1093/jnci/djm115 (2007). DOI: 10.1093/jnci/djm115",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "UGT1A1*28 genotype and irinotecan-induced neutropenia: Dose matters"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1093/jnci/djm115",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR20",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "34548598459",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "99"},
                                "pagerange": {
                                    "@first": "1290",
                                    "@last": "1295"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Hoskins",
                                    "ce:indexed-name": "Hoskins J.M."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "R.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Goldberg",
                                    "ce:indexed-name": "Goldberg R.M."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Qu",
                                    "ce:indexed-name": "Qu P."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "J.G.",
                                    "@_fa": "true",
                                    "ce:surname": "Ibrahim",
                                    "ce:indexed-name": "Ibrahim J.G."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "H.L.",
                                    "@_fa": "true",
                                    "ce:surname": "McLeod",
                                    "ce:indexed-name": "McLeod H.L."
                                }
                            ]},
                            "ref-sourcetitle": "J. Natl. Cancer Inst."
                        },
                        "ce:source-text": "Hoskins, J. M., Goldberg, R. M., Qu, P., Ibrahim, J. G. & McLeod, H. L. UGT1A1*28 genotype and irinotecan-induced neutropenia: Dose matters. J. Natl. Cancer Inst. 99, 1290\u20131295. 10.1093/jnci/djm115 (2007). DOI: 10.1093/jnci/djm115"
                    },
                    {
                        "ref-fulltext": "Xu, J. M. et al. Severe irinotecan-induced toxicity in a patient with UGT1A1 28 and UGT1A1 6 polymorphisms. World J. Gastroenterol. 19, 3899\u20133903. 10.3748/wjg.v19.i24.3899 (2013). DOI: 10.3748/wjg.v19.i24.3899",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Severe irinotecan-induced toxicity in a patient with UGT1A1 28 and UGT1A1 6 polymorphisms"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.3748/wjg.v19.i24.3899",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR21",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84879583361",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "19"},
                                "pagerange": {
                                    "@first": "3899",
                                    "@last": "3903"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "J.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Xu",
                                    "ce:indexed-name": "Xu J.M."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "World J. Gastroenterol."
                        },
                        "ce:source-text": "Xu, J. M. et al. Severe irinotecan-induced toxicity in a patient with UGT1A1 28 and UGT1A1 6 polymorphisms. World J. Gastroenterol. 19, 3899\u20133903. 10.3748/wjg.v19.i24.3899 (2013). DOI: 10.3748/wjg.v19.i24.3899"
                    },
                    {
                        "ref-fulltext": "Shulman, K. et al. Clinical implications of UGT1A1*28 genotype testing in colorectal cancer patients. Cancer 117, 3156\u20133162. 10.1002/cncr.25735 (2011). DOI: 10.1002/cncr.25735",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Clinical implications of UGT1A1*28 genotype testing in colorectal cancer patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1002/cncr.25735",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR22",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "79959965073",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "117"},
                                "pagerange": {
                                    "@first": "3156",
                                    "@last": "3162"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Shulman",
                                    "ce:indexed-name": "Shulman K."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer"
                        },
                        "ce:source-text": "Shulman, K. et al. Clinical implications of UGT1A1*28 genotype testing in colorectal cancer patients. Cancer 117, 3156\u20133162. 10.1002/cncr.25735 (2011). DOI: 10.1002/cncr.25735"
                    },
                    {
                        "ref-fulltext": "Zhou, C. F. et al. UGT1A1 gene polymorphisms and the toxicities of FOLFIRI in Chinese Han patients with gastrointestinal cancer. Anticancer Agents Med. Chem. 13, 235\u2013241 (2013). DOI: 10.2174/1871520611313020008",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "UGT1A1 gene polymorphisms and the toxicities of FOLFIRI in Chinese Han patients with gastrointestinal cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.2174/1871520611313020008",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR23",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84876711885",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "13"},
                                "pagerange": {
                                    "@first": "235",
                                    "@last": "241"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DC%2BC3sXktFekt7c%3D",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "C.F.",
                                    "@_fa": "true",
                                    "ce:surname": "Zhou",
                                    "ce:indexed-name": "Zhou C.F."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Anticancer Agents Med. Chem."
                        },
                        "ce:source-text": "Zhou, C. F. et al. UGT1A1 gene polymorphisms and the toxicities of FOLFIRI in Chinese Han patients with gastrointestinal cancer. Anticancer Agents Med. Chem. 13, 235\u2013241 (2013). DOI: 10.2174/1871520611313020008"
                    },
                    {
                        "ref-fulltext": "Wang, Y. et al. Distribution of uridine diphosphate glucuronosyltransferase 1A polymorphisms and their role in irinotecan-induced toxicity in patients with cancer. Oncol. Lett. 14, 5743\u20135752. 10.3892/ol.2017.6933 (2017). DOI: 10.3892/ol.2017.6933",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Distribution of uridine diphosphate glucuronosyltransferase 1A polymorphisms and their role in irinotecan-induced toxicity in patients with cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.3892/ol.2017.6933",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR24",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85030176971",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "14"},
                                "pagerange": {
                                    "@first": "5743",
                                    "@last": "5752"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Wang",
                                    "ce:indexed-name": "Wang Y."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Oncol. Lett."
                        },
                        "ce:source-text": "Wang, Y. et al. Distribution of uridine diphosphate glucuronosyltransferase 1A polymorphisms and their role in irinotecan-induced toxicity in patients with cancer. Oncol. Lett. 14, 5743\u20135752. 10.3892/ol.2017.6933 (2017). DOI: 10.3892/ol.2017.6933"
                    },
                    {
                        "ref-fulltext": "Rouits, E. et al. Relevance of different UGT1A1 polymorphisms in irinotecan-induced toxicity: A molecular and clinical study of 75 patients. Clin. Cancer Res. 10, 5151\u20135159. 10.1158/1078-0432.ccr-03-0548 (2004). DOI: 10.1158/1078-0432.ccr-03-0548",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2004"},
                            "ref-title": {"ref-titletext": "Relevance of different UGT1A1 polymorphisms in irinotecan-induced toxicity: A molecular and clinical study of 75 patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1158/1078-0432.ccr-03-0548",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR25",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "4143101374",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "10"},
                                "pagerange": {
                                    "@first": "5151",
                                    "@last": "5159"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Rouits",
                                    "ce:indexed-name": "Rouits E."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin. Cancer Res."
                        },
                        "ce:source-text": "Rouits, E. et al. Relevance of different UGT1A1 polymorphisms in irinotecan-induced toxicity: A molecular and clinical study of 75 patients. Clin. Cancer Res. 10, 5151\u20135159. 10.1158/1078-0432.ccr-03-0548 (2004). DOI: 10.1158/1078-0432.ccr-03-0548"
                    },
                    {
                        "ref-fulltext": "Akiyama, Y. et al. Association of ABCC2 genotype with efficacy of first-line FOLFIRI in Japanese patients with advanced colorectal cancer. Drug Metab. Pharmacokinet. 27, 325\u2013335 (2012). DOI: 10.2133/dmpk.DMPK-11-RG-128",
                        "@id": "26",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Association of ABCC2 genotype with efficacy of first-line FOLFIRI in Japanese patients with advanced colorectal cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.2133/dmpk.DMPK-11-RG-128",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR26",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84863199899",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "27"},
                                "pagerange": {
                                    "@first": "325",
                                    "@last": "335"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DC%2BC38Xht1GiurvF",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Akiyama",
                                    "ce:indexed-name": "Akiyama Y."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Drug Metab. Pharmacokinet."
                        },
                        "ce:source-text": "Akiyama, Y. et al. Association of ABCC2 genotype with efficacy of first-line FOLFIRI in Japanese patients with advanced colorectal cancer. Drug Metab. Pharmacokinet. 27, 325\u2013335 (2012). DOI: 10.2133/dmpk.DMPK-11-RG-128"
                    },
                    {
                        "ref-fulltext": "Han, J. Y., Lim, H. S., Park, Y. H., Lee, S. Y. & Lee, J. S. Integrated pharmacogenetic prediction of irinotecan pharmacokinetics and toxicity in patients with advanced non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands) 63, 115\u2013120. 10.1016/j.lungcan.2007.12.003 (2009). DOI: 10.1016/j.lungcan.2007.12.003",
                        "@id": "27",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Integrated pharmacogenetic prediction of irinotecan pharmacokinetics and toxicity in patients with advanced non-small cell lung cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.lungcan.2007.12.003",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR27",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "57649103563",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "63"},
                                "pagerange": {
                                    "@first": "115",
                                    "@last": "120"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J.Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Han",
                                    "ce:indexed-name": "Han J.Y."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "H.S.",
                                    "@_fa": "true",
                                    "ce:surname": "Lim",
                                    "ce:indexed-name": "Lim H.S."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "Y.H.",
                                    "@_fa": "true",
                                    "ce:surname": "Park",
                                    "ce:indexed-name": "Park Y.H."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "S.Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Lee",
                                    "ce:indexed-name": "Lee S.Y."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "J.S.",
                                    "@_fa": "true",
                                    "ce:surname": "Lee",
                                    "ce:indexed-name": "Lee J.S."
                                }
                            ]},
                            "ref-sourcetitle": "Lung Cancer (Amsterdam, Netherlands)"
                        },
                        "ce:source-text": "Han, J. Y., Lim, H. S., Park, Y. H., Lee, S. Y. & Lee, J. S. Integrated pharmacogenetic prediction of irinotecan pharmacokinetics and toxicity in patients with advanced non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands) 63, 115\u2013120. 10.1016/j.lungcan.2007.12.003 (2009). DOI: 10.1016/j.lungcan.2007.12.003"
                    },
                    {
                        "ref-fulltext": "Onoue, M. et al. UGT1A1*6 polymorphism is most predictive of severe neutropenia induced by irinotecan in Japanese cancer patients. Int. J. Clin. Oncol. 14, 136\u2013142. 10.1007/s10147-008-0821-z (2009). DOI: 10.1007/s10147-008-0821-z",
                        "@id": "28",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "UGT1A1*6 polymorphism is most predictive of severe neutropenia induced by irinotecan in Japanese cancer patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1007/s10147-008-0821-z",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR28",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "65349181626",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "14"},
                                "pagerange": {
                                    "@first": "136",
                                    "@last": "142"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Onoue",
                                    "ce:indexed-name": "Onoue M."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Int. J. Clin. Oncol."
                        },
                        "ce:source-text": "Onoue, M. et al. UGT1A1*6 polymorphism is most predictive of severe neutropenia induced by irinotecan in Japanese cancer patients. Int. J. Clin. Oncol. 14, 136\u2013142. 10.1007/s10147-008-0821-z (2009). DOI: 10.1007/s10147-008-0821-z"
                    },
                    {
                        "ref-fulltext": "Yang, C. et al. Relationship between UGT1A1*6/*28 polymorphisms and severe toxicities in Chinese patients with pancreatic or biliary tract cancer treated with irinotecan-containing regimens. Drug Des. Dev. Ther. 9, 3677\u20133683. 10.2147/dddt.s86750 (2015). DOI: 10.2147/dddt.s86750",
                        "@id": "29",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Relationship between UGT1A1*6/*28 polymorphisms and severe toxicities in Chinese patients with pancreatic or biliary tract cancer treated with irinotecan-containing regimens"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.2147/dddt.s86750",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR29",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84937720195",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "9"},
                                "pagerange": {
                                    "@first": "3677",
                                    "@last": "3683"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Yang",
                                    "ce:indexed-name": "Yang C."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Drug Des. Dev. Ther."
                        },
                        "ce:source-text": "Yang, C. et al. Relationship between UGT1A1*6/*28 polymorphisms and severe toxicities in Chinese patients with pancreatic or biliary tract cancer treated with irinotecan-containing regimens. Drug Des. Dev. Ther. 9, 3677\u20133683. 10.2147/dddt.s86750 (2015). DOI: 10.2147/dddt.s86750"
                    },
                    {
                        "ref-fulltext": "Han, F. F. et al. Associations between UGT1A1*6 or UGT1A1*6/*28 polymorphisms and irinotecan-induced neutropenia in Asian cancer patients. Cancer Chemother. Pharmacol. 73, 779\u2013788. 10.1007/s00280-014-2405-0 (2014). DOI: 10.1007/s00280-014-2405-0",
                        "@id": "30",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Associations between UGT1A1*6 or UGT1A1*6/*28 polymorphisms and irinotecan-induced neutropenia in Asian cancer patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1007/s00280-014-2405-0",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR30",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84898058478",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "73"},
                                "pagerange": {
                                    "@first": "779",
                                    "@last": "788"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "F.F.",
                                    "@_fa": "true",
                                    "ce:surname": "Han",
                                    "ce:indexed-name": "Han F.F."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Chemother. Pharmacol."
                        },
                        "ce:source-text": "Han, F. F. et al. Associations between UGT1A1*6 or UGT1A1*6/*28 polymorphisms and irinotecan-induced neutropenia in Asian cancer patients. Cancer Chemother. Pharmacol. 73, 779\u2013788. 10.1007/s00280-014-2405-0 (2014). DOI: 10.1007/s00280-014-2405-0"
                    },
                    {
                        "ref-fulltext": "Moriya, H. et al. Association between the low-dose irinotecan regimen-induced occurrence of grade 4 neutropenia and genetic variants of UGT1A1 in patients with gynecological cancers. Oncol. Lett. 7, 2035\u20132040. 10.3892/ol.2014.2046 (2014). DOI: 10.3892/ol.2014.2046",
                        "@id": "31",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Association between the low-dose irinotecan regimen-induced occurrence of grade 4 neutropenia and genetic variants of UGT1A1 in patients with gynecological cancers"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.3892/ol.2014.2046",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR31",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84898895193",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "7"},
                                "pagerange": {
                                    "@first": "2035",
                                    "@last": "2040"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Moriya",
                                    "ce:indexed-name": "Moriya H."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Oncol. Lett."
                        },
                        "ce:source-text": "Moriya, H. et al. Association between the low-dose irinotecan regimen-induced occurrence of grade 4 neutropenia and genetic variants of UGT1A1 in patients with gynecological cancers. Oncol. Lett. 7, 2035\u20132040. 10.3892/ol.2014.2046 (2014). DOI: 10.3892/ol.2014.2046"
                    },
                    {
                        "ref-fulltext": "Fardel, O., Jigorel, E., Le Vee, M. & Payen, L. Physiological, pharmacological and clinical features of the multidrug resistance protein 2. Biomed. Pharmacother. 59, 104\u2013114. 10.1016/j.biopha.2005.01.005 (2005). DOI: 10.1016/j.biopha.2005.01.005",
                        "@id": "32",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2005"},
                            "ref-title": {"ref-titletext": "Physiological, pharmacological and clinical features of the multidrug resistance protein 2"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.biopha.2005.01.005",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR32",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "15744368796",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "59"},
                                "pagerange": {
                                    "@first": "104",
                                    "@last": "114"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "O.",
                                    "@_fa": "true",
                                    "ce:surname": "Fardel",
                                    "ce:indexed-name": "Fardel O."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Jigorel",
                                    "ce:indexed-name": "Jigorel E."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Le Vee",
                                    "ce:indexed-name": "Le Vee M."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Payen",
                                    "ce:indexed-name": "Payen L."
                                }
                            ]},
                            "ref-sourcetitle": "Biomed. Pharmacother."
                        },
                        "ce:source-text": "Fardel, O., Jigorel, E., Le Vee, M. & Payen, L. Physiological, pharmacological and clinical features of the multidrug resistance protein 2. Biomed. Pharmacother. 59, 104\u2013114. 10.1016/j.biopha.2005.01.005 (2005). DOI: 10.1016/j.biopha.2005.01.005"
                    },
                    {
                        "ref-fulltext": "Suzuki, H. & Sugiyama, Y. Single nucleotide polymorphisms in multidrug resistance associated protein 2 (MRP2/ABCC2): Its impact on drug disposition. Adv. Drug Deliv. Rev. 54, 1311\u20131331 (2002). DOI: 10.1016/S0169-409X(02)00075-3",
                        "@id": "33",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2002"},
                            "ref-title": {"ref-titletext": "Single nucleotide polymorphisms in multidrug resistance associated protein 2 (MRP2/ABCC2): Its impact on drug disposition"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/S0169-409X(02)00075-3",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR33",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0037131880",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "54"},
                                "pagerange": {
                                    "@first": "1311",
                                    "@last": "1331"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DC%2BD38XotF2ju74%3D",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Suzuki",
                                    "ce:indexed-name": "Suzuki H."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Sugiyama",
                                    "ce:indexed-name": "Sugiyama Y."
                                }
                            ]},
                            "ref-sourcetitle": "Adv. Drug Deliv. Rev."
                        },
                        "ce:source-text": "Suzuki, H. & Sugiyama, Y. Single nucleotide polymorphisms in multidrug resistance associated protein 2 (MRP2/ABCC2): Its impact on drug disposition. Adv. Drug Deliv. Rev. 54, 1311\u20131331 (2002). DOI: 10.1016/S0169-409X(02)00075-3"
                    },
                    {
                        "ref-fulltext": "Han, J. Y. et al. Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan-pharmacokinetics and clinical outcome in patients with advanced non-small cell lung cancer. Cancer 110, 138\u2013147. 10.1002/cncr.22760 (2007). DOI: 10.1002/cncr.22760",
                        "@id": "34",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan-pharmacokinetics and clinical outcome in patients with advanced non-small cell lung cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CR34",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "10.1002/cncr.22760",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "34250825286",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "110"},
                                "pagerange": {
                                    "@first": "138",
                                    "@last": "147"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "J.Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Han",
                                    "ce:indexed-name": "Han J.Y."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer"
                        },
                        "ce:source-text": "Han, J. Y. et al. Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan-pharmacokinetics and clinical outcome in patients with advanced non-small cell lung cancer. Cancer 110, 138\u2013147. 10.1002/cncr.22760 (2007). DOI: 10.1002/cncr.22760"
                    },
                    {
                        "ref-fulltext": "Yan, L. et al. Effects of UGT1A1*6, UGT1A1*28, and ABCB1-3435C>T polymorphisms on irinotecan induced toxicity in Chinese cancer patients. Int. J. Clin. Pharmacol. Ther. 54, 193\u2013199. 10.5414/cp202442 (2016). DOI: 10.5414/cp202442",
                        "@id": "35",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Effects of UGT1A1*6, UGT1A1*28, and ABCB1-3435C>T polymorphisms on irinotecan induced toxicity in Chinese cancer patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.5414/cp202442",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR35",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84962301190",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "54"},
                                "pagerange": {
                                    "@first": "193",
                                    "@last": "199"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Yan",
                                    "ce:indexed-name": "Yan L."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Int. J. Clin. Pharmacol. Ther."
                        },
                        "ce:source-text": "Yan, L. et al. Effects of UGT1A1*6, UGT1A1*28, and ABCB1-3435C>T polymorphisms on irinotecan induced toxicity in Chinese cancer patients. Int. J. Clin. Pharmacol. Ther. 54, 193\u2013199. 10.5414/cp202442 (2016). DOI: 10.5414/cp202442"
                    },
                    {
                        "ref-fulltext": "Cote, J. F. et al. UGT1A1 polymorphism can predict hematologic toxicity in patients treated with irinotecan. Clin. Cancer Res. 13, 3269\u20133275. 10.1158/1078-0432.CCR-06-2290 (2007). DOI: 10.1158/1078-0432.CCR-06-2290",
                        "@id": "36",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "UGT1A1 polymorphism can predict hematologic toxicity in patients treated with irinotecan"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1158/1078-0432.CCR-06-2290",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR36",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "34250629236",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "13"},
                                "pagerange": {
                                    "@first": "3269",
                                    "@last": "3275"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "J.F.",
                                    "@_fa": "true",
                                    "ce:surname": "Cote",
                                    "ce:indexed-name": "Cote J.F."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin. Cancer Res."
                        },
                        "ce:source-text": "Cote, J. F. et al. UGT1A1 polymorphism can predict hematologic toxicity in patients treated with irinotecan. Clin. Cancer Res. 13, 3269\u20133275. 10.1158/1078-0432.CCR-06-2290 (2007). DOI: 10.1158/1078-0432.CCR-06-2290"
                    },
                    {
                        "ref-fulltext": "Nakatomi, K. et al. Transport of 7-ethyl-10-hydroxycamptothecin (SN-38) by breast cancer resistance protein ABCG2 in human lung cancer cells. Biochem. Biophys. Res. Commun. 288, 827\u2013832. 10.1006/bbrc.2001.5850 (2001). DOI: 10.1006/bbrc.2001.5850",
                        "@id": "37",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2001"},
                            "ref-title": {"ref-titletext": "Transport of 7-ethyl-10-hydroxycamptothecin (SN-38) by breast cancer resistance protein ABCG2 in human lung cancer cells"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1006/bbrc.2001.5850",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR37",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0035834595",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "288"},
                                "pagerange": {
                                    "@first": "827",
                                    "@last": "832"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Nakatomi",
                                    "ce:indexed-name": "Nakatomi K."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Biochem. Biophys. Res. Commun."
                        },
                        "ce:source-text": "Nakatomi, K. et al. Transport of 7-ethyl-10-hydroxycamptothecin (SN-38) by breast cancer resistance protein ABCG2 in human lung cancer cells. Biochem. Biophys. Res. Commun. 288, 827\u2013832. 10.1006/bbrc.2001.5850 (2001). DOI: 10.1006/bbrc.2001.5850"
                    },
                    {
                        "ref-fulltext": "de Jong, F. A. et al. ABCG2 pharmacogenetics: Ethnic differences in allele frequency and assessment of influence on irinotecan disposition. Clin. Cancer Res. 10, 5889\u20135894. 10.1158/1078-0432.ccr-04-0144 (2004). DOI: 10.1158/1078-0432.ccr-04-0144",
                        "@id": "38",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2004"},
                            "ref-title": {"ref-titletext": "ABCG2 pharmacogenetics: Ethnic differences in allele frequency and assessment of influence on irinotecan disposition"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1158/1078-0432.ccr-04-0144",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR38",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "4444381535",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "10"},
                                "pagerange": {
                                    "@first": "5889",
                                    "@last": "5894"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "F.A.",
                                    "@_fa": "true",
                                    "ce:surname": "de Jong",
                                    "ce:indexed-name": "de Jong F.A."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin. Cancer Res."
                        },
                        "ce:source-text": "de Jong, F. A. et al. ABCG2 pharmacogenetics: Ethnic differences in allele frequency and assessment of influence on irinotecan disposition. Clin. Cancer Res. 10, 5889\u20135894. 10.1158/1078-0432.ccr-04-0144 (2004). DOI: 10.1158/1078-0432.ccr-04-0144"
                    },
                    {
                        "ref-fulltext": "Li, M. et al. ABC transporter polymorphisms are associated with irinotecan pharmacokinetics and neutropenia. Pharmacogenom. J. 18, 35\u201342. 10.1038/tpj.2016.75 (2018). DOI: 10.1038/tpj.2016.75",
                        "@id": "39",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "ABC transporter polymorphisms are associated with irinotecan pharmacokinetics and neutropenia"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1038/tpj.2016.75",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR39",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84995480863",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "18"},
                                "pagerange": {
                                    "@first": "35",
                                    "@last": "42"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Li",
                                    "ce:indexed-name": "Li M."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Pharmacogenom. J."
                        },
                        "ce:source-text": "Li, M. et al. ABC transporter polymorphisms are associated with irinotecan pharmacokinetics and neutropenia. Pharmacogenom. J. 18, 35\u201342. 10.1038/tpj.2016.75 (2018). DOI: 10.1038/tpj.2016.75"
                    },
                    {
                        "ref-fulltext": "Haaz, M. C., Rivory, L., Riche, C., Vernillet, L. & Robert, J. Metabolism of irinotecan (CPT-11) by human hepatic microsomes: Participation of cytochrome P-450 3A and drug interactions. Cancer Res. 58, 468\u2013472 (1998).",
                        "@id": "40",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1998"},
                            "ref-title": {"ref-titletext": "Metabolism of irinotecan (CPT-11) by human hepatic microsomes: Participation of cytochrome P-450 3A and drug interactions"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CR40",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0032005259",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "58"},
                                "pagerange": {
                                    "@first": "468",
                                    "@last": "472"
                                }
                            },
                            "ref-text": "COI: 1:STN:280:DyaK1c7hslaqtw%3D%3D, PID: 9458091",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M.C.",
                                    "@_fa": "true",
                                    "ce:surname": "Haaz",
                                    "ce:indexed-name": "Haaz M.C."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Rivory",
                                    "ce:indexed-name": "Rivory L."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Riche",
                                    "ce:indexed-name": "Riche C."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Vernillet",
                                    "ce:indexed-name": "Vernillet L."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Robert",
                                    "ce:indexed-name": "Robert J."
                                }
                            ]},
                            "ref-sourcetitle": "Cancer Res."
                        },
                        "ce:source-text": "Haaz, M. C., Rivory, L., Riche, C., Vernillet, L. & Robert, J. Metabolism of irinotecan (CPT-11) by human hepatic microsomes: Participation of cytochrome P-450 3A and drug interactions. Cancer Res. 58, 468\u2013472 (1998)."
                    },
                    {
                        "ref-fulltext": "Falvella, F. S. et al. Undetected toxicity risk in pharmacogenetic testing for dihydropyrimidine dehydrogenase. Int. J. Mol. Sci. 16, 8884\u20138895. 10.3390/ijms16048884 (2015). DOI: 10.3390/ijms16048884",
                        "@id": "41",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Undetected toxicity risk in pharmacogenetic testing for dihydropyrimidine dehydrogenase"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.3390/ijms16048884",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR41",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84928139184",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "16"},
                                "pagerange": {
                                    "@first": "8884",
                                    "@last": "8895"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "F.S.",
                                    "@_fa": "true",
                                    "ce:surname": "Falvella",
                                    "ce:indexed-name": "Falvella F.S."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Int. J. Mol. Sci."
                        },
                        "ce:source-text": "Falvella, F. S. et al. Undetected toxicity risk in pharmacogenetic testing for dihydropyrimidine dehydrogenase. Int. J. Mol. Sci. 16, 8884\u20138895. 10.3390/ijms16048884 (2015). DOI: 10.3390/ijms16048884"
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60015887",
            "affilname": "Faculty of Medicine Ramathibodi Hospital, Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015887",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199578",
            "affilname": "Ramathibodi Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pathum Thani",
            "@id": "60023366",
            "affilname": "Rangsit University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60023366",
            "affiliation-country": "Thailand"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85089227432",
        "dc:description": "Genetic polymorphisms in drug metabolizing enzymes and drug transporters may affect irinotecan toxicity. Although genetic polymorphisms have been shown to influence the irinotecan toxicity, data are limited in Thai population. Thus, the aim of this study was to assess the allele and genotype frequencies and the relationship between CYP3A4/5, DPYD, UGT1A1, ABCB1, and ABCC2 genetic variations and irinotecan-induced toxicity in Thai colorectal cancer patients. One hundred and thirty-two patients were genotyped, and the effect of genetic variations on irinotecan-induced toxicity was assessed in 66 patients who received irinotecan-based chemotherapy. Allele frequencies of ABCB1 c.1236C > T, ABCB1 c.3435C > T, ABCC2 c.3972C > T, ABCG2 c.421C > A, CYP3A4*1B, CYP3A4*18, CYP3A5*3, DPYD*5, UGT1A1*28, and UGT1A1*6 were 0.67, 0.43, 0.23, 0.27, 0.01, 0.02, 0.64, 0.19, 0.16, and 0.09, respectively. DPYD*2A and DPYD c.1774C > T variants were not detected in our study population. The ABCC2 c.3972C > T was significantly associated with grade 1\u20134 neutropenia (P < 0.012) at the first cycle. Patients carrying both UGT1A1*28 and *6 were significantly associated with severe neutropenia at the first (P < 0.001) and second (P = 0.017) cycles. In addition, patients carrying UG1A1*28 and *6 had significantly lower absolute neutrophil count (ANC) nadir at first (P < 0.001) and second (P = 0.001) cycles. This finding suggests that UGT1A1*28, *6, and ABCC2 c.3972C > T might be an important predictor for irinotecan-induced severe neutropenia.",
        "pubmed-id": "32778670",
        "prism:coverDate": "2020-12-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85089227432",
        "dc:creator": {"author": [{
            "ce:given-name": "Chalirmporn",
            "preferred-name": {
                "ce:given-name": "Chalirmporn",
                "ce:initials": "C.",
                "ce:surname": "Atasilp",
                "ce:indexed-name": "Atasilp C."
            },
            "@seq": "1",
            "ce:initials": "C.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60023366",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60023366"
                },
                {
                    "@id": "60015887",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015887"
                },
                {
                    "@id": "60199578",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578"
                }
            ],
            "ce:surname": "Atasilp",
            "@auid": "56465100500",
            "author-url": "https://api.elsevier.com/content/author/author_id/56465100500",
            "ce:indexed-name": "Atasilp C."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85089227432"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85089227432&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85089227432&origin=inward"
            }
        ],
        "source-id": "21100200805",
        "citedby-count": "15",
        "prism:volume": "10",
        "subtype": "ar",
        "dc:title": "Effect of drug metabolizing enzymes and transporters in Thai colorectal cancer patients treated with irinotecan-based chemotherapy",
        "openaccess": "1",
        "prism:issn": "20452322",
        "publishercopyright": "© 2020, The Author(s).",
        "article-number": "13486",
        "prism:issueIdentifier": "1",
        "subtypeDescription": "Article",
        "prism:publicationName": "Scientific Reports",
        "openaccessFlag": "true",
        "prism:doi": "10.1038/s41598-020-70351-0",
        "dc:identifier": "SCOPUS_ID:85089227432",
        "dc:publisher": "Nature Research"
    },
    "idxterms": {"mainterm": [
        {
            "$": "Adult",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Aged",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Alleles",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "ATP Binding Cassette Transporter, Subfamily B, Member 1",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "ATP-Binding Cassette Transporters",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Colorectal Neoplasms",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Cytochrome P-450 CYP3A",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Female",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Gene Frequency",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Genetic Variation",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Genotype",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Glucuronosyltransferase",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Humans",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Irinotecan",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Male",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Membrane Transport Proteins",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Middle Aged",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Multidrug Resistance-Associated Proteins",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Neutropenia",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Polymorphism, Genetic",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Thailand",
            "@weight": "b",
            "@candidate": "n"
        }
    ]},
    "language": {"@xml:lang": "eng"},
    "authkeywords": null,
    "subject-areas": {"subject-area": [{
        "@_fa": "true",
        "$": "Multidisciplinary",
        "@code": "1000",
        "@abbrev": "MULT"
    }]},
    "authors": {"author": [
        {
            "ce:given-name": "Chalirmporn",
            "preferred-name": {
                "ce:given-name": "Chalirmporn",
                "ce:initials": "C.",
                "ce:surname": "Atasilp",
                "ce:indexed-name": "Atasilp C."
            },
            "@seq": "1",
            "ce:initials": "C.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60023366",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60023366"
                },
                {
                    "@id": "60015887",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015887"
                },
                {
                    "@id": "60199578",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578"
                }
            ],
            "ce:surname": "Atasilp",
            "@auid": "56465100500",
            "author-url": "https://api.elsevier.com/content/author/author_id/56465100500",
            "ce:indexed-name": "Atasilp C."
        },
        {
            "ce:given-name": "Phichai",
            "preferred-name": {
                "ce:given-name": "Phichai",
                "ce:initials": "P.",
                "ce:surname": "Chansriwong",
                "ce:indexed-name": "Chansriwong P."
            },
            "@seq": "2",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60015887",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015887"
            },
            "ce:surname": "Chansriwong",
            "@auid": "37007308200",
            "author-url": "https://api.elsevier.com/content/author/author_id/37007308200",
            "ce:indexed-name": "Chansriwong P."
        },
        {
            "ce:given-name": "Ekaphop",
            "preferred-name": {
                "ce:given-name": "Ekaphop",
                "ce:initials": "E.",
                "ce:surname": "Sirachainan",
                "ce:indexed-name": "Sirachainan E."
            },
            "@seq": "3",
            "ce:initials": "E.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60015887",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015887"
            },
            "ce:surname": "Sirachainan",
            "@auid": "6602792356",
            "author-url": "https://api.elsevier.com/content/author/author_id/6602792356",
            "ce:indexed-name": "Sirachainan E."
        },
        {
            "ce:given-name": "Thanyanan",
            "preferred-name": {
                "ce:given-name": "Thanyanan",
                "ce:initials": "T.",
                "ce:surname": "Reungwetwattana",
                "ce:indexed-name": "Reungwetwattana T."
            },
            "@seq": "4",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60015887",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015887"
            },
            "ce:surname": "Reungwetwattana",
            "@auid": "37120809500",
            "author-url": "https://api.elsevier.com/content/author/author_id/37120809500",
            "ce:indexed-name": "Reungwetwattana T."
        },
        {
            "ce:given-name": "Suwannee",
            "preferred-name": {
                "ce:given-name": "Suwannee",
                "ce:initials": "S.",
                "ce:surname": "Sirilerttrakul",
                "ce:indexed-name": "Sirilerttrakul S."
            },
            "@seq": "5",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60015887",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015887"
            },
            "ce:surname": "Sirilerttrakul",
            "@auid": "7801642293",
            "author-url": "https://api.elsevier.com/content/author/author_id/7801642293",
            "ce:indexed-name": "Sirilerttrakul S."
        },
        {
            "ce:given-name": "Monpat",
            "preferred-name": {
                "ce:given-name": "Monpat",
                "ce:initials": "M.",
                "ce:surname": "Chamnanphon",
                "ce:indexed-name": "Chamnanphon M."
            },
            "@seq": "6",
            "ce:initials": "M.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Chamnanphon",
            "@auid": "55441642400",
            "author-url": "https://api.elsevier.com/content/author/author_id/55441642400",
            "ce:indexed-name": "Chamnanphon M."
        },
        {
            "ce:given-name": "Apichaya",
            "preferred-name": {
                "ce:given-name": "Apichaya",
                "ce:initials": "A.",
                "ce:surname": "Puangpetch",
                "ce:indexed-name": "Puangpetch A."
            },
            "@seq": "7",
            "ce:initials": "A.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60015887",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015887"
                },
                {
                    "@id": "60199578",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578"
                }
            ],
            "ce:surname": "Puangpetch",
            "@auid": "55200307900",
            "author-url": "https://api.elsevier.com/content/author/author_id/55200307900",
            "ce:indexed-name": "Puangpetch A."
        },
        {
            "ce:given-name": "Chonlaphat",
            "preferred-name": {
                "ce:given-name": "Chonlaphat",
                "ce:initials": "C.",
                "ce:surname": "Sukasem",
                "ce:indexed-name": "Sukasem C."
            },
            "@seq": "8",
            "ce:initials": "C.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60015887",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015887"
                },
                {
                    "@id": "60199578",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578"
                }
            ],
            "ce:surname": "Sukasem",
            "@auid": "57209265337",
            "author-url": "https://api.elsevier.com/content/author/author_id/57209265337",
            "ce:indexed-name": "Sukasem C."
        }
    ]}
}}